The Valley Desk

NCT01863550 · Interventional trial

Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Overall registry status Active not recruiting

Phase 3

Conditions Plasma Cell Myeloma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov